Next-generation agents include CagriSema (semaglutide + cagrilintide, NDA filed December 2025, showing 22.7% weight loss), retatrutide (triple GIP/GLP-1/glucagon agonist, 28.7% weight loss in Phase 3), and orforglipron (oral non-peptide GLP-1, submitted to FDA)
But it is especially important to pair microdosing with lifestyle modifications, because the lower receptor activation at sub-therapeutic doses means you are relying more on behavioral changes to drive results during the early weeks
In addition, Semaglutide and Tirzepatide are drugs that show the potential to improve metabolic health and reduce A1C hemoglobin
How Naturyz Helps You Take Better Care of Your Skin At Naturyz, we believe skincare should go beyond surface-level beauty trends
Introduction to Ipamorelin and CJC-1295 Peptides Ipamorelin is a selective ghrelin receptor (GHSR-1a) agonist developed to stimulate growth hormone release without significantly elevating cortisol or prolactin
From GLP-1s to Insulin: What to Know About Peptides Peptides promise health benefits, but do they actually work